Pluri PLUR
NASDAQ PLUR
$1.71 -0.05 (-2.84%)
As of: Aug 21, 2026 · 3:59 PM EDT

Pluri (PLUR) Non-Current Deffered Revenue (2011 - 2015)

Pluri (PLUR) posted quarterly Non-Current Deffered Revenue of $2.4 million for Q3 2015, down 13.77% year-over-year from $2.8 million in Q3 2014, and down 3.85% quarter-over-quarter from $2.5 million in Q2 2015.

Pluri (PLUR) Non-Current Deffered Revenue (2011 - 2015) Analysis & Trends

Pluri (PLUR) has reported Non-Current Deffered Revenue for 5 consecutive years, with $2.4 million the latest figure, recorded in Q3 2015.

  • In Q3 2015, Non-Current Deffered Revenue fell 13.77% year-over-year to $2.4 million; the TTM figure through Sep 2015 stood at $2.4 million (down 13.77% YoY), while the FY2015 annual figure was $2.5 million, down 13.31% from the prior year.
  • Non-Current Deffered Revenue declined to $2.4 million in Q3 2015 per PLUR's latest filing, from $2.5 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $3.9 million in Q3 2011 and bottomed at $3116.0 in Q4 2012.
  • Historically, Non-Current Deffered Revenue has averaged $2.9 million across 5 years, with a median of $3.0 million in 2013.
  • Annual changes were most pronounced in 2012 — Non-Current Deffered Revenue plunged 99.92% — and 2013, when it jumped 97332.61%.
  • Pluri's Non-Current Deffered Revenue stood at $3.7 million in 2011, then slumped by 99.92% to $3116.0 in 2012, then surged by 97332.61% to $3.0 million in 2013, then fell by 12.48% to $2.7 million in 2014, then slipped by 10.69% to $2.4 million in 2015.
  • Business Quant data shows PLUR's Non-Current Deffered Revenue at $2.4 million in Q3 2015, $2.5 million in Q2 2015, and $2.7 million in Q4 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 220.40 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 147.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Pluri 16.21 Mn 3.72 Mn 86,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2015 2.37 Mn
Jun 30, 2015 2.47 Mn
Dec 31, 2014 2.66 Mn
Sep 30, 2014 2.75 Mn
Jun 30, 2014 2.85 Mn
Mar 31, 2014 2.94 Mn
Dec 31, 2013 3.04 Mn
Sep 30, 2013 3.13 Mn
Jun 30, 2013 3.23 Mn
Mar 31, 2013 2.92 Mn
Dec 31, 2012 3,116.00
Sep 30, 2012 3.31 Mn
Jun 30, 2012 3.51 Mn
Mar 31, 2012 3.46 Mn
Dec 31, 2011 3.69 Mn
Sep 30, 2011 3.92 Mn